Sunshine Biopharma Inc. Disposal Group, Including Discontinued Operation, Gross Profit (Loss)
Sunshine Biopharma Inc. (SBFM) reported Disposal Group, Including Discontinued Operation, Gross Profit (Loss) of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss · last filed 2021-03-30
- Sunshine Biopharma Inc. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2020-12-31 was $0.00.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2020-09-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2020-06-30 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, gross profit (loss) for the quarter ending 2020-03-31 was $0.00, a 100.00% decline year-over-year.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, gross profit (loss) for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, gross profit (loss) for fiscal 2019 was $37.60K, a 25.02% decline from fiscal 2018.
- Sunshine Biopharma Inc. disposal group, including discontinued operation, gross profit (loss) for fiscal 2018 was $50.15K.
| Period end | Disposal Group, Including Discontinued Operation, Gross Profit (Loss) 3 month | Disposal Group, Including Discontinued Operation, Gross Profit (Loss) 3 month as first filed | Disposal Group, Including Discontinued Operation, Gross Profit (Loss) 6 month | Disposal Group, Including Discontinued Operation, Gross Profit (Loss) 9 month | Disposal Group, Including Discontinued Operation, Gross Profit (Loss) 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $0.00 10-K · filed 2021-03-30 | |
| 2020-09-30 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 2 quarters · filed 2020-11-12 | $0.00 10-Q · filed 2020-11-12 | $0.00 derived: sum of 4 quarters · filed 2021-03-30 | |
| 2020-06-30 | $0.00 10-Q/A · filed 2020-08-31 | $0.00 10-Q/A · filed 2020-08-31 | $0.00 derived: sum of 3 quarters · filed 2021-03-30 | $37.60K derived: sum of 4 quarters · filed 2021-03-30 | |
| 2020-03-31 | $0.00 10-Q · filed 2020-05-18 | $0.00 derived: sum of 2 quarters · filed 2021-03-30 | $37.60K derived: sum of 3 quarters · filed 2021-03-30 | $75.20K derived: sum of 4 quarters · filed 2021-03-30 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $37.60K derived: sum of 2 quarters · filed 2021-03-30 | $75.20K derived: sum of 3 quarters · filed 2021-03-30 | $37.60K 10-K · filed 2021-03-30 | |
| 2019-09-30 | $37.60K 10-Q · filed 2020-11-12 | $0.00 10-Q · filed 2019-11-13 | $75.20K derived: sum of 2 quarters · filed 2020-11-12 | $37.60K 10-Q · filed 2020-11-12 | $112.81K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $37.60K 10-Q/A · filed 2020-08-31 | $0.00 10-Q · filed 2019-08-15 | $37.60K 10-Q/A · filed 2020-08-31 | $75.20K derived: sum of 3 quarters · filed 2020-08-31 | $111.92K derived: sum of 4 quarters · filed 2020-08-31 |
| 2019-03-31 | $37.60K 10-Q · filed 2020-05-18 | $37.60K derived: sum of 2 quarters · filed 2020-05-18 | $74.32K derived: sum of 3 quarters · filed 2020-05-18 | $93.03K derived: sum of 4 quarters · filed 2020-05-18 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-05-01 | $36.72K derived: sum of 2 quarters · filed 2020-05-01 | $55.43K derived: sum of 3 quarters · filed 2020-05-01 | $50.15K 10-K · filed 2020-05-01 | |
| 2018-09-30 | $36.72K 10-Q · filed 2019-11-13 | $55.43K derived: sum of 2 quarters · filed 2019-11-13 | $50.15K 10-Q · filed 2019-11-13 | ||
| 2018-06-30 | $18.71K 10-Q · filed 2019-08-15 | $13.43K 10-Q · filed 2019-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |